scholarly journals Home Based Aerobic Training and the Changes in Adipsin Levels and Visceral Adiposity Index (VAI) in Women with Polycystic Ovary Syndrome

2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Nahid Mohammadi Javid ◽  
Nasser Behpoor ◽  
Vahid Tadibi

Background: Polycystic ovary syndrome (PCOS) is prevalent in 5% - 8% of women of reproductive age and is one of the most important causes of infertility. Objectives: The aim of this study was to investigate the effect of home-made aerobic activity on the level of changes in adipsin levels and visceral adiposity (VAI) in woman patients with chronic polycystic ovary syndrome in Kermanshah city. Materials and Methods: This study was carried out among 24 women with PCOS in 2017. The samples were 12 people in the intervention group and 12 people in the control group (referred to Kermanshah health centers). The intervention group then performed home-based aerobic training for 16 weeks. Serum levels of adiposity and visceral adiposity were measured before and after the exercise program through blood sampling. SPSS V.22 software was used for data analysis and t-test with independent sample and paired t-test. Results: There was a significant difference in the visceral adiposity index (VAI) after 16 weeks of aerobic exercise in the intervention group (P = 0.014). However, adipsin level changes were not statistically significant in the control and control groups. (P = 0.097). Conclusion: Aerobic exercise under house supervision has a favorable effect on the visceral adiposity index in women with PCOS and can be recommended as a safe treatment for these patients.

2017 ◽  
Vol 125 (05) ◽  
pp. 307-315 ◽  
Author(s):  
Fernanda Mario ◽  
Scheila Graff ◽  
Poli Spritzer

AbstractPolycystic ovary syndrome (PCOS) is a common condition in women of reproductive age. 2 PCOS phenotypes (classic and ovulatory) are currently recognized as the most prevalent, with important differences in terms of cardiometabolic features. We studied the performance of different adiposity indexes to predict preclinical metabolic alterations and cardiovascular risk in 234 women with PCOS (173 with classic and 61 with ovulatory PCOS) and 129 controls. Performance of waist circumference, waist-to-height ratio, conicity index, lipid accumulation product, and visceral adiposity index was assessed based on HOMA-IR ≥ 3.8 as reference standard for screening preclinical metabolic alterations and cardiovascular risk factors in each group. Lipid accumulation product had the best accuracy for classic PCOS, and visceral adiposity index had the best accuracy for ovulatory PCOS. By applying the cutoff point of lipid accumulation product<34, we identified a subgroup of patients without cardiometabolic alterations (P<0.05) in the group with classic PCOS, a population at higher risk for hypertension, dyslipidemia, and impaired glucose tolerance. In ovulatory PCOS, visceral adiposity index ≥ 1.32 was capable of detecting women with significantly higher blood pressure and less favorable glycemic and lipid variables as compared to ovulatory PCOS with lower visceral adiposity index (P<0.05). These results suggest LAP ≥ 34 as the best marker for classic PCOS, and VAI ≥ 1.32 for ovulatory PCOS women. Both indexes can be easily calculated with measures obtained in routine clinical practice and may be useful to detect cardiometabolic risk and secure early interventions.


Sign in / Sign up

Export Citation Format

Share Document